Click for best price
Remicade infliximab Drug Market Size, Share 2024
| Market size in 2023 |
US$ 2405.1 million
|
Forecast Market size by 2030 |
US$ 3697.5 million
|
| Growth Rate |
CAGR of 5.9% |
Number of Pages |
101 Pages |
This research report provides a comprehensive analysis of the Remicade (infliximab) Drug market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Remicade (infliximab) Drug market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Remicade (infliximab) Drug, challenges faced by the industry, and potential opportunities for market players.
The global Remicade (infliximab) Drug market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Remicade (infliximab) Drug market presents opportunities for various stakeholders, including Crohn's Disease, Pediatric Crohn's Disease. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Remicade (infliximab) Drug market. Additionally, the growing consumer demand present avenues for market expansion.
The global Remicade (infliximab) Drug market was valued at US$ 2405.1 million in 2023 and is projected to reach US$ 3697.5 million by 2030, at a CAGR of 5.9% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Remicade (infliximab) Drug market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Remicade (infliximab) Drug market.
Market Overview: The report provides a comprehensive overview of the Remicade (infliximab) Drug market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Brands Drugs, Generic Drugs), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Remicade (infliximab) Drug market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Remicade (infliximab) Drug market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Remicade (infliximab) Drug market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Remicade (infliximab) Drug market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Remicade (infliximab) Drug market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Remicade (infliximab) Drug market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Remicade (infliximab) Drug, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Remicade (infliximab) Drug market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
- Remicade (infliximab) Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Brands Drugs
- Generic Drugs
Market segment by Application
- Crohn's Disease
- Pediatric Crohn's Disease
- Ulcerative Colitis
- Pediatric Ulcerative Colitis
- Other
Global Remicade (infliximab) Drug Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Major players covered
- J & J
- Pfizer
- Celltrion Healthcare
- Epirus Biopharmaceuticals
- Samsung Bioepsis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Remicade (infliximab) Drug, market overview.
Chapter 2: Global Remicade (infliximab) Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Remicade (infliximab) Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Remicade (infliximab) Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Remicade (infliximab) Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Remicade (infliximab) Drug Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 2405.1 million
|
| Forecast Market size by 2030 |
US$ 3697.5 million
|
| Growth Rate |
CAGR of 5.9% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
101 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Remicade (infliximab) Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Remicade (infliximab) Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Remicade (infliximab) Drug Overall Market Size
2.1 Global Remicade (infliximab) Drug Market Size: 2023 VS 2030
2.2 Global Remicade (infliximab) Drug Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Remicade (infliximab) Drug Sales: 2019-2030
3 Company Landscape
3.1 Top Remicade (infliximab) Drug Players in Global Market
3.2 Top Global Remicade (infliximab) Drug Companies Ranked by Revenue
3.3 Global Remicade (infliximab) Drug Revenue by Companies
3.4 Global Remicade (infliximab) Drug Sales by Companies
3.5 Global Remicade (infliximab) Drug Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Remicade (infliximab) Drug Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Remicade (infliximab) Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Remicade (infliximab) Drug Players in Global Market
3.8.1 List of Global Tier 1 Remicade (infliximab) Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Remicade (infliximab) Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Remicade (infliximab) Drug Market Size Markets, 2023 & 2030
4.1.2 Brands Drugs
4.1.3 Generic Drugs
4.2 By Type - Global Remicade (infliximab) Drug Revenue & Forecasts
4.2.1 By Type - Global Remicade (infliximab) Drug Revenue, 2019-2024
4.2.2 By Type - Global Remicade (infliximab) Drug Revenue, 2025-2030
4.2.3 By Type - Global Remicade (infliximab) Drug Revenue Market Share, 2019-2030
4.3 By Type - Global Remicade (infliximab) Drug Sales & Forecasts
4.3.1 By Type - Global Remicade (infliximab) Drug Sales, 2019-2024
4.3.2 By Type - Global Remicade (infliximab) Drug Sales, 2025-2030
4.3.3 By Type - Global Remicade (infliximab) Drug Sales Market Share, 2019-2030
4.4 By Type - Global Remicade (infliximab) Drug Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Remicade (infliximab) Drug Market Size, 2023 & 2030
5.1.2 Crohn's Disease
5.1.3 Pediatric Crohn's Disease
5.1.4 Ulcerative Colitis
5.1.5 Pediatric Ulcerative Colitis
5.1.6 Other
5.2 By Application - Global Remicade (infliximab) Drug Revenue & Forecasts
5.2.1 By Application - Global Remicade (infliximab) Drug Revenue, 2019-2024
5.2.2 By Application - Global Remicade (infliximab) Drug Revenue, 2025-2030
5.2.3 By Application - Global Remicade (infliximab) Drug Revenue Market Share, 2019-2030
5.3 By Application - Global Remicade (infliximab) Drug Sales & Forecasts
5.3.1 By Application - Global Remicade (infliximab) Drug Sales, 2019-2024
5.3.2 By Application - Global Remicade (infliximab) Drug Sales, 2025-2030
5.3.3 By Application - Global Remicade (infliximab) Drug Sales Market Share, 2019-2030
5.4 By Application - Global Remicade (infliximab) Drug Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Remicade (infliximab) Drug Market Size, 2023 & 2030
6.2 By Region - Global Remicade (infliximab) Drug Revenue & Forecasts
6.2.1 By Region - Global Remicade (infliximab) Drug Revenue, 2019-2024
6.2.2 By Region - Global Remicade (infliximab) Drug Revenue, 2025-2030
6.2.3 By Region - Global Remicade (infliximab) Drug Revenue Market Share, 2019-2030
6.3 By Region - Global Remicade (infliximab) Drug Sales & Forecasts
6.3.1 By Region - Global Remicade (infliximab) Drug Sales, 2019-2024
6.3.2 By Region - Global Remicade (infliximab) Drug Sales, 2025-2030
6.3.3 By Region - Global Remicade (infliximab) Drug Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Remicade (infliximab) Drug Revenue, 2019-2030
6.4.2 By Country - North America Remicade (infliximab) Drug Sales, 2019-2030
6.4.3 US Remicade (infliximab) Drug Market Size, 2019-2030
6.4.4 Canada Remicade (infliximab) Drug Market Size, 2019-2030
6.4.5 Mexico Remicade (infliximab) Drug Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Remicade (infliximab) Drug Revenue, 2019-2030
6.5.2 By Country - Europe Remicade (infliximab) Drug Sales, 2019-2030
6.5.3 Germany Remicade (infliximab) Drug Market Size, 2019-2030
6.5.4 France Remicade (infliximab) Drug Market Size, 2019-2030
6.5.5 U.K. Remicade (infliximab) Drug Market Size, 2019-2030
6.5.6 Italy Remicade (infliximab) Drug Market Size, 2019-2030
6.5.7 Russia Remicade (infliximab) Drug Market Size, 2019-2030
6.5.8 Nordic Countries Remicade (infliximab) Drug Market Size, 2019-2030
6.5.9 Benelux Remicade (infliximab) Drug Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Remicade (infliximab) Drug Revenue, 2019-2030
6.6.2 By Region - Asia Remicade (infliximab) Drug Sales, 2019-2030
6.6.3 China Remicade (infliximab) Drug Market Size, 2019-2030
6.6.4 Japan Remicade (infliximab) Drug Market Size, 2019-2030
6.6.5 South Korea Remicade (infliximab) Drug Market Size, 2019-2030
6.6.6 Southeast Asia Remicade (infliximab) Drug Market Size, 2019-2030
6.6.7 India Remicade (infliximab) Drug Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Remicade (infliximab) Drug Revenue, 2019-2030
6.7.2 By Country - South America Remicade (infliximab) Drug Sales, 2019-2030
6.7.3 Brazil Remicade (infliximab) Drug Market Size, 2019-2030
6.7.4 Argentina Remicade (infliximab) Drug Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Remicade (infliximab) Drug Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Remicade (infliximab) Drug Sales, 2019-2030
6.8.3 Turkey Remicade (infliximab) Drug Market Size, 2019-2030
6.8.4 Israel Remicade (infliximab) Drug Market Size, 2019-2030
6.8.5 Saudi Arabia Remicade (infliximab) Drug Market Size, 2019-2030
6.8.6 UAE Remicade (infliximab) Drug Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 J & J
7.1.1 J & J Company Summary
7.1.2 J & J Business Overview
7.1.3 J & J Remicade (infliximab) Drug Major Product Offerings
7.1.4 J & J Remicade (infliximab) Drug Sales and Revenue in Global (2019-2024)
7.1.5 J & J Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Remicade (infliximab) Drug Major Product Offerings
7.2.4 Pfizer Remicade (infliximab) Drug Sales and Revenue in Global (2019-2024)
7.2.5 Pfizer Key News & Latest Developments
7.3 Celltrion Healthcare
7.3.1 Celltrion Healthcare Company Summary
7.3.2 Celltrion Healthcare Business Overview
7.3.3 Celltrion Healthcare Remicade (infliximab) Drug Major Product Offerings
7.3.4 Celltrion Healthcare Remicade (infliximab) Drug Sales and Revenue in Global (2019-2024)
7.3.5 Celltrion Healthcare Key News & Latest Developments
7.4 Epirus Biopharmaceuticals
7.4.1 Epirus Biopharmaceuticals Company Summary
7.4.2 Epirus Biopharmaceuticals Business Overview
7.4.3 Epirus Biopharmaceuticals Remicade (infliximab) Drug Major Product Offerings
7.4.4 Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales and Revenue in Global (2019-2024)
7.4.5 Epirus Biopharmaceuticals Key News & Latest Developments
7.5 Samsung Bioepsis
7.5.1 Samsung Bioepsis Company Summary
7.5.2 Samsung Bioepsis Business Overview
7.5.3 Samsung Bioepsis Remicade (infliximab) Drug Major Product Offerings
7.5.4 Samsung Bioepsis Remicade (infliximab) Drug Sales and Revenue in Global (2019-2024)
7.5.5 Samsung Bioepsis Key News & Latest Developments
8 Global Remicade (infliximab) Drug Production Capacity, Analysis
8.1 Global Remicade (infliximab) Drug Production Capacity, 2019-2030
8.2 Remicade (infliximab) Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Remicade (infliximab) Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Remicade (infliximab) Drug Supply Chain Analysis
10.1 Remicade (infliximab) Drug Industry Value Chain
10.2 Remicade (infliximab) Drug Upstream Market
10.3 Remicade (infliximab) Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Remicade (infliximab) Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Remicade (infliximab) Drug in Global Market
Table 2. Top Remicade (infliximab) Drug Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Remicade (infliximab) Drug Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Remicade (infliximab) Drug Revenue Share by Companies, 2019-2024
Table 5. Global Remicade (infliximab) Drug Sales by Companies, (K Units), 2019-2024
Table 6. Global Remicade (infliximab) Drug Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Remicade (infliximab) Drug Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Remicade (infliximab) Drug Product Type
Table 9. List of Global Tier 1 Remicade (infliximab) Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Remicade (infliximab) Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Remicade (infliximab) Drug Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Remicade (infliximab) Drug Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Remicade (infliximab) Drug Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Remicade (infliximab) Drug Sales (K Units), 2019-2024
Table 15. By Type - Global Remicade (infliximab) Drug Sales (K Units), 2025-2030
Table 16. By Application ? Global Remicade (infliximab) Drug Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Remicade (infliximab) Drug Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Remicade (infliximab) Drug Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Remicade (infliximab) Drug Sales (K Units), 2019-2024
Table 20. By Application - Global Remicade (infliximab) Drug Sales (K Units), 2025-2030
Table 21. By Region ? Global Remicade (infliximab) Drug Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Remicade (infliximab) Drug Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Remicade (infliximab) Drug Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Remicade (infliximab) Drug Sales (K Units), 2019-2024
Table 25. By Region - Global Remicade (infliximab) Drug Sales (K Units), 2025-2030
Table 26. By Country - North America Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Remicade (infliximab) Drug Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Remicade (infliximab) Drug Sales, (K Units), 2019-2024
Table 29. By Country - North America Remicade (infliximab) Drug Sales, (K Units), 2025-2030
Table 30. By Country - Europe Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Remicade (infliximab) Drug Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Remicade (infliximab) Drug Sales, (K Units), 2019-2024
Table 33. By Country - Europe Remicade (infliximab) Drug Sales, (K Units), 2025-2030
Table 34. By Region - Asia Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Remicade (infliximab) Drug Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Remicade (infliximab) Drug Sales, (K Units), 2019-2024
Table 37. By Region - Asia Remicade (infliximab) Drug Sales, (K Units), 2025-2030
Table 38. By Country - South America Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Remicade (infliximab) Drug Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Remicade (infliximab) Drug Sales, (K Units), 2019-2024
Table 41. By Country - South America Remicade (infliximab) Drug Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Remicade (infliximab) Drug Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Remicade (infliximab) Drug Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Remicade (infliximab) Drug Sales, (K Units), 2025-2030
Table 46. J & J Company Summary
Table 47. J & J Remicade (infliximab) Drug Product Offerings
Table 48. J & J Remicade (infliximab) Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. J & J Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Remicade (infliximab) Drug Product Offerings
Table 52. Pfizer Remicade (infliximab) Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. Pfizer Key News & Latest Developments
Table 54. Celltrion Healthcare Company Summary
Table 55. Celltrion Healthcare Remicade (infliximab) Drug Product Offerings
Table 56. Celltrion Healthcare Remicade (infliximab) Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. Celltrion Healthcare Key News & Latest Developments
Table 58. Epirus Biopharmaceuticals Company Summary
Table 59. Epirus Biopharmaceuticals Remicade (infliximab) Drug Product Offerings
Table 60. Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. Epirus Biopharmaceuticals Key News & Latest Developments
Table 62. Samsung Bioepsis Company Summary
Table 63. Samsung Bioepsis Remicade (infliximab) Drug Product Offerings
Table 64. Samsung Bioepsis Remicade (infliximab) Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 65. Samsung Bioepsis Key News & Latest Developments
Table 66. Remicade (infliximab) Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 67. Global Remicade (infliximab) Drug Capacity Market Share of Key Manufacturers, 2022-2024
Table 68. Global Remicade (infliximab) Drug Production by Region, 2019-2024 (K Units)
Table 69. Global Remicade (infliximab) Drug Production by Region, 2025-2030 (K Units)
Table 70. Remicade (infliximab) Drug Market Opportunities & Trends in Global Market
Table 71. Remicade (infliximab) Drug Market Drivers in Global Market
Table 72. Remicade (infliximab) Drug Market Restraints in Global Market
Table 73. Remicade (infliximab) Drug Raw Materials
Table 74. Remicade (infliximab) Drug Raw Materials Suppliers in Global Market
Table 75. Typical Remicade (infliximab) Drug Downstream
Table 76. Remicade (infliximab) Drug Downstream Clients in Global Market
Table 77. Remicade (infliximab) Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Remicade (infliximab) Drug Segment by Type in 2023
Figure 2. Remicade (infliximab) Drug Segment by Application in 2023
Figure 3. Global Remicade (infliximab) Drug Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Remicade (infliximab) Drug Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Remicade (infliximab) Drug Revenue, 2019-2030 (US$, Mn)
Figure 7. Remicade (infliximab) Drug Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Remicade (infliximab) Drug Revenue in 2023
Figure 9. By Type - Global Remicade (infliximab) Drug Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Remicade (infliximab) Drug Revenue Market Share, 2019-2030
Figure 11. By Type - Global Remicade (infliximab) Drug Sales Market Share, 2019-2030
Figure 12. By Type - Global Remicade (infliximab) Drug Price (USD/Unit), 2019-2030
Figure 13. By Application - Global Remicade (infliximab) Drug Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Remicade (infliximab) Drug Revenue Market Share, 2019-2030
Figure 15. By Application - Global Remicade (infliximab) Drug Sales Market Share, 2019-2030
Figure 16. By Application - Global Remicade (infliximab) Drug Price (USD/Unit), 2019-2030
Figure 17. By Region - Global Remicade (infliximab) Drug Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Remicade (infliximab) Drug Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Remicade (infliximab) Drug Revenue Market Share, 2019-2030
Figure 20. By Region - Global Remicade (infliximab) Drug Sales Market Share, 2019-2030
Figure 21. By Country - North America Remicade (infliximab) Drug Revenue Market Share, 2019-2030
Figure 22. By Country - North America Remicade (infliximab) Drug Sales Market Share, 2019-2030
Figure 23. US Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Remicade (infliximab) Drug Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Remicade (infliximab) Drug Sales Market Share, 2019-2030
Figure 28. Germany Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2030
Figure 29. France Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Remicade (infliximab) Drug Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Remicade (infliximab) Drug Sales Market Share, 2019-2030
Figure 37. China Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2030
Figure 41. India Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Remicade (infliximab) Drug Revenue Market Share, 2019-2030
Figure 43. By Country - South America Remicade (infliximab) Drug Sales Market Share, 2019-2030
Figure 44. Brazil Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Remicade (infliximab) Drug Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Remicade (infliximab) Drug Sales Market Share, 2019-2030
Figure 48. Turkey Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Remicade (infliximab) Drug Revenue, (US$, Mn), 2019-2030
Figure 52. Global Remicade (infliximab) Drug Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Remicade (infliximab) Drug by Region, 2023 VS 2030
Figure 54. Remicade (infliximab) Drug Industry Value Chain
Figure 55. Marketing Channels
